Tetrahydrocoptisine was found to modulate postmenopausal osteoporosis by directly interacting with disease-related proteins such as IL6, IL1B, and TNF, in addition to affecting disease-associated biological functions and indirectly interacting with other disease-related proteins. Here, IL1B is linked to postmenopausal osteoporosis.